INBOK WEE: Open Payments
NPI 1740900687 · LAKEWOOD, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$718 in 37 payments from 11 companies in 2025. Trend: 2023 $368 · 2024 $502 · 2025 $718
Food & beverage: $718
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $255 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 8 | $169 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $66 |
| Lilly USA, LLC | 2 | $54 |
| GlaxoSmithKline, LLC. | 2 | $41 |
| Kowa Pharmaceuticals America, Inc. | 2 | $37 |
| Sumitomo Pharma America, Inc. | 1 | $24 |
| Exact Sciences Corporation | 1 | $23 |
| Novo Nordisk Inc | 1 | $23 |
| AstraZeneca Pharmaceuticals LP | 1 | $19 |
Products named: JARDIANCE, LINZESS, Kerendia, CREON, ZORYVE, GEMTESA, SHINGRIX, Cologuard Collection Kit.
Industry payments across WA — which companies pay providers there.
